Automated Cannabis Testing Market Size, Share, And Growth Report 2032

What is the Automated Cannabis Testing Market Size?

The global Automated Cannabis Testing market size was worth around USD 1.63 billion in 2023 and is predicted to reach around USD 4.34 billion by 2032, with a compound annual growth rate (CAGR) of roughly 11.50% between 2024 and 2032. The Automated Cannabis Testing Market is driven by the increasing legalization of cannabis and the enforcement of stringent regulatory mandates ensuring product safety and quality. The report examines the primary drivers, challenges, and restraints shaping global demand for the Automated Cannabis Testing market throughout the forecast period and identifies high-growth opportunities across the industry.

Request Free Sample

Automated Cannabis Testing Market: Overview

Automated cannabis testing encompasses the sophisticated utilization of advanced analytical instruments and robotic systems to meticulously evaluate the chemical composition, potency, and purity of cannabis products. This comprehensive testing framework is systematically designed to rapidly detect active cannabinoids, intricate terpenes, residual solvents, dangerous pesticides, heavy metals, and harmful microbial contaminants, assuring that finished products are entirely safe for human consumption and strictly meet mandatory regulatory standards.

By replacing tedious manual laboratory processes with highly synchronized automated solutions, testing facilities can significantly increase sample throughput, drastically minimize human error, and completely standardize their workflows, thereby guaranteeing the highest level of accuracy, reproducibility, and reliability in cannabis diagnostics.

Key Insights

• As per the analysis shared by our research analyst, the global automated cannabis testing market is expected to grow annually at a CAGR of around 11.50% (2025-2034).
• In terms of revenue, the global automated cannabis testing market size was valued at nearly USD 1.63 billion in 2024 and is projected to reach USD 4.34 billion by 2034.
• The global market is driven by the rapid legalization of medical marijuana, stringent regulatory compliance requirements, and rising consumer demand for standardized, contaminant-free cannabis therapeutics.
• Based on the Product Type, the chromatography-based analyzer segment dominated the global market with a massive 59.3% share
• Based on the Application, the pain management segment dominated the global market with a significant 52.7% share
• Based on the End-use, the laboratories segment dominated the global market with a substantial 48.6% share
• Based on region, North America dominated the global market with a commanding share, driven by a highly progressive and complex state-level regulatory landscape

Automated Cannabis Testing Market: Dynamics

The global automated cannabis testing market has enormous opportunities in the upcoming future. The global automated cannabis testing market is expected to grow at a significant rate within the forecast period. The growth of the automated cannabis testing market can be attributed to the increasing adoption of laboratory information management systems (LIMS) in automated cannabis testing, as LIMS is an extremely powerful tool for testing cannabis in laboratories.

Also, the increasing number of cannabis testing labs in prominent countries such as the U.S., Canada, etc., coupled with the legalization of cannabis for medical distribution, is expected to propel the market growth over the forecast years. Moreover, the rising number of medical cannabis clubs and awareness of medical benefits related to the consumption of cannabis is expected to bolster the growth of the automated cannabis testing market over the forecast years.

Request Free Sample

Automated Cannabis Testing Market: Segmentation

The Automated Cannabis Testing market is segmented by product type, application, end-use, and region.

Based on the product type, the global automated cannabis testing market has been classified into chromatography-based analyzer type and spectroscopy-based analyzer type. The chromatography-based analyzer type held the largest market share in 2023. The chromatography-based analyzer type segment is anticipated to grow at a rapid pace on account of its fast and effective results. In addition to this, various key players are also offering specialized chromatography instruments in the market for cannabis testing, which is expected to further the growth of the chromatography-based analyzer type segment over the forecast years.

Based on application, the global automated cannabis testing market is segmented into pain management, seizures, sclerosis, and others. Among these, the pain management segment holds the maximum segment share currently and is expected to witness significant growth over the forecast period. Usage of cannabis in treating diseases such as chronic pain, arthritis, neurological disorders, and other diseases is expected to stimulate the growth of this segment over the forecast years.  Also, the increasing need for effective pain management remedies on a global scale is expected to boost the demand for the automated cannabis testing market over the forecast timeframe.

Based on end-use, the global automated cannabis testing market has been segmented into consumers, regulators, laboratories, and others. The laboratories segment held the largest market share in 2023, on account of an increasing number of cannabis testing laboratories across the globe.

Automated Cannabis Testing Market: Report Scope

Automated Cannabis Testing Market: Regional Analysis

Why will North America continue to dominate the global market during the projection period?

North America held the largest market share in 2023 owing to the increasing legalization for the distribution of cannabis as a medical product across the region. Moreover, the rising number of testing laboratories and increasing cannabis cultivation across the region are expected to accelerate regional market growth over the forecast years. Europe is projected to witness remarkable market growth during the forecast period. This can be attributed to the new medical cannabis legislation and approval of the production license since March 2017. Also, the rising demand for medical cannabis among patients and prescribers is expected to further propel the growth of automated cannabis testing market in Europe over the forecast timeline.

Global Automated Cannabis Testing Market: Competitive Landscape

The global Automated Cannabis Testing market is dominated by players:

• Medicinal Genomics Corp
• Hamilton Company
• PerkinElmer Inc.
• Agilent Technologies Inc.
• Todaro Robotics
• QUANTUM ANALYTICS
• Shimadzu Scientific Instruments

The Global Automated Cannabis Testing Market is segmented as follows:

By Product Type

• Chromatography-Based Analyzer
• Spectroscopy-Based Analyzer

By Application

• Pain Management
• Seizures
• Sclerosis
• Others

By End-Use

• Consumers
• Regulators
• Laboratories
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America